D
Precision BioSciences D
D
DTIL
7.31000
USD
-0.03
(-0.41%)
مغلق
حجم التداول
17,227
الربح لكل سهم
-2
العائد الربحي
-
P/E
-3
حجم السوق
188,614,426
المقالات
العنوان: Precision BioSciences
القطاع: Healthcare
الصناعة: Biotechnology
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).